Unique Associations of DNA Methylation Regions With 24-Hour Blood Pressure Phenotypes in Blacks

Michelle L. Roberts,Theodore A. Kotchen,Xiaoqing Pan,Yingchuan Li,Chun Yang,Pengyuan Liu,Tao Wang,Purushottam W. Laud,Thomas H. Chelius,Yannick Munyura,David L. Mattson,Yong Liu,Allen W. Cowley,Srividya Kidambi,Mingyu Liang
DOI: https://doi.org/10.1161/hypertensionaha.121.18584
IF: 9.8968
2022-01-09
Hypertension
Abstract:Epigenetic marks (eg, DNA methylation) may capture the effect of gene-environment interactions. DNA methylation is involved in blood pressure (BP) regulation and hypertension development; however, no studies have evaluated its relationship with 24-hour BP phenotypes (daytime, nighttime, and 24-hour average BPs). We examined the association of whole blood DNA methylation with 24-hour BP phenotypes and clinic BPs in a discovery cohort of 281 Blacks using reduced representation bisulfite sequencing. We developed a deep and region-specific methylation sequencing method, Bisulfite ULtrapLEx Targeted Sequencing and utilized it to validate our findings in a separate validation cohort (n=117). Analysis of 38 215 DNA methylation regions (MRs), derived from 1 549 368 CpG sites across the genome, identified up to 72 regions that were significantly associated with 24-hour BP phenotypes. No MR was significantly associated with clinic BP. Two to 3 MRs were significantly associated with various 24-hour BP phenotypes after adjustment for age, sex, and body mass index. Together, these MRs explained up to 16.5% of the variance of 24-hour average BP, while age, sex, and BMI explained up to 11.0% of the variance. Analysis of one of the MRs in an independent cohort using Bisulfite ULtrapLEx Targeted Sequencing confirmed its association with 24-hour average BP phenotype. We identified several MRs that explain a substantial portion of variances in 24-hour BP phenotypes, which might be excellent markers of cumulative effect of factors influencing 24-hour BP levels. The Bisulfite ULtrapLEx Targeted Sequencing workflow has potential to be suitable for clinical testing and population screenings on a large scale.
peripheral vascular disease
What problem does this paper attempt to address?